Andreia Bilé-Silva

Dr. Andreia Bilé-Silva


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2024 in Acta Urológica Portuguesa
Verified
Journal Article
Open access
PDF file
ABAndreia Bilé-Silva
Andreia Bilé-Silva
PDPaulo Jorge Dinis
Paulo Jorge Dinis
FGFrederico Portugal Gaspar
Frederico Portugal Gaspar
RFRita Rodrigues Fonseca
Rita Rodrigues Fonseca
JSJosé Carlos Santos
José Carlos Santos
Introduction: Prostate biopsy (PB) may be performed by either the transrectal (TR) or transperineal (TP) approach. Cancer detection rates seem to be comparable between the two approaches. However, evidence suggests a reduced infection risk and a higher detection of tumours localised in the anterior zone of the prostate with the TP route. TP-PB is currently recommended as a first-line procedure for the diagnosis of prostate cancer (PCa) whenever available. We sought to report the initial results of in-office freehand TP-PB under local anaesthesia in the outpatient setting. Methods: We conducted a prospective study with consecutive sampling with data from men submitted to TP-PB from Sep/2019 to Sep/2021, in a tertiary care centre. A questionnaire was carried out to appraise the pain related to the procedure on a pain numerical rating scale from 0 to 10. Presenting PSA, biopsy result and characteristics and complications that motivated a visit to the emergency department–ED – until 1 month after the PB were analysed. Antibiotic (AB) prophylaxis was not provided to any of the patients undergoing TP-PB. TP-PB was performed under local anaesthesia by freehand method. Results: A hundred and eight (108) patients underwent TP-PB. The mean age was 66±9 years old. The median presenting PSA was comparable in patients with positive and negative PB results (7.7 ng/mL, p=0.11). Overall, 67/108 (62%) patients had PCa diagnosed. Clinically significant (cs) PCa (ISUP=2) was diagnosed in 42/67 (63%) patients. The TP approach allowed the diagnosis of anterior zone PCa in 61% (41/67) of the patients (anterior zone csPCa in 63% of these), 7% (5/67) had exclusively anterior zone pathological findings. Complications leading to an ED visit were recorded in only one patient. Patients reported only mild levels of discomfort related to the anaesthesia infiltration (3±3) and to the introduction of the US transducer (3±3). Globally, the patients ascribed a pain of 3±3 to the entire procedure. Conclusion: Freehand TP-PB under local anaesthesia, without AB prophylaxis, is a well-tolerated and safe procedure, feasible as an outpatient procedure. TP-PB provides an easy access to the anterior zone of the prostate allowing for the diagnosis of previously missed PCa. Introdução: A biópsia prostática (BxP) pode ser realizada por via transretal (TR) ou transperineal (TP). As taxas de deteção de neoplasia parecem comparáveis entre ambas as abordagens. Contudo, a evidência sugere um menor risco infeccioso e uma maior taxa de deteção de tumores localizados na porção anterior da próstata com a via TP. A BxP-TP é atualmente recomendada como procedimento de primeira linha no diagnóstico de cancro da próstata (CaP), sempre que disponível. O trabalho tem como objetivo reportar os resultados iniciais de BxP-TP “mãos-livres” sob anestesia local, em regime de ambulatório. Métodos: Realizou-se um estudo prospetivo com amostragem consecutiva e dados de homens submetidos a BxP-TP entre set/2019 e set/2021, num centro hospitalar terciário. Disponibilizou-se um questionário para avaliar a dor associada ao procedimento numa escala numérica de 0 a 10. Analisaram-se os PSA inicial, resultado e características da biópsia e complicações que motivaram uma ida ao Serviço de Urgência (SU) até um mês após a realização da BxP-TP. Não se procedeu a administração de antibioterapia profilática em nenhumdosdoentessubmetidosaBxP-TP. A BxP-TP foi efetuada sob anestesia local pelo método de “mãos-livres”. Resultados: Um total de 108 doentes foram submetidos a BxP-TP.Aidademédiafoi66±9anos. O PSA inicial mediano foi comparável em doentes com BxP-TP com resultados positivo e negativo (7,7 ng/mL, p=0,11). No total, 67/108 (62%) doentes foram diagnosticados com CaP, clinicamente significativo (CaPcs) (ISUP=2) em 42/67 (63%) destes. A via TP permitiu diagnosticar CaP da zona anterior em 61% (41/ /67) dos doentes (CaPcs da zona anterior em 63% dos mesmos), 7% (5/67) tinham apenas positividade na zona anterior da próstata. Apenas um doente teve complicações a condicionar necessidade de ida ao SU. O procedimento causou apenas níveis ligeiros de desconforto associado à instilação de anestesia (3±3) e à introdução da sonda ecográfica (3±3). Globalmente, os doentes atribuíram uma dor de 3±3 ao procedimento na sua íntegra. Conclusão: A BxP-TP “mãos-livres” sob anestesia local, sem antibioterapia profilática, é um procedimento bem tolerado, seguro, exequível em regime ambulatorial. A via TP proporciona um acesso fácil à zona anterior da próstata, permitindo diagnosticar neoplasias cujo diagnóstico previamente se falhava.

28 September 2026 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
EDElizabeth Day
Elizabeth Day
ABAndreia Bilé-Silva
Andreia Bilé-Silva
ABAmit Bhudia
Amit Bhudia
AVAbhishek Vigneshkumar
Abhishek Vigneshkumar
GPGeorgi Petkov
Georgi Petkov
ZTZafer Tandogdu
Zafer Tandogdu

30 September 2026 in BJU International
Verified
Journal Article
Open access
ABAndreia Bilé-Silva
Andreia Bilé-Silva
PRPrabhakar Rajan
Prabhakar Rajan
BLBenjamin Lamb
Benjamin Lamb
MÖMEHMET ÖZALEVLİ
MEHMET ÖZALEVLİ
LDLouise Dickinson
Louise Dickinson
ZTZafer Tandogdu
Zafer Tandogdu
Objectives: To examine the association between the nerve‐sparing (NS) technique applied during radical prostatectomy (RP) and early oncological and continence outcomes in patients with Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE)‐defined high‐risk prostate cancer (PCa) undergoing robot‐assisted RP (RARP) within a structured patient‐specific surgical planning (PSSP) pathway. Patients and Methods: A retrospective single‐centre cohort study of 1385 patients who underwent primary RARP between 2021 and 2022 was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. Patients were stratified into three groups according to the number of STAMPEDE‐defined high‐risk factors: none, one, and two or more. Outcomes were compared across these cohorts and between NS‐ and non‐NS (nNS)‐ RARP, within each risk stratum. Results: Overall, NS‐RARP was performed in 75.4% of patients (1044/1385). In the STAMPEDE‐defined high‐risk cohort (two or more high‐risk criteria) 57.3% (150/262) of patients underwent some sort of NS. Among those with at least two STAMPEDE‐defined risk factors, oncological outcomes were similar between NS and nNS surgery (positive surgical margin rate 21.3% vs 23.2%, P = 0.72; 12‐month biochemical recurrence rate 6.7% vs 5.4%, P = 0.9), and urinary continence rates at 3 and 12 months were also similar ( P = 0.2 and P = 0.5, respectively). However, high‐risk patients undergoing NS‐RARP used significantly fewer pads at 12 months ( P = 0.03). Conclusion: In a contemporary RARP cohort within a PSSP pathway, NS was feasible in over half of high‐risk patients and was not associated with worse short‐term oncological outcomes. Although pad‐free continence rates were similar between NS and nNS groups, patients undergoing NS‐RARP used significantly fewer pads at 12 months, suggesting a potential functional benefit that warrants further prospective evaluation of NS strategies in selected cases.

17 April 2026 in Precision Oncology
Verified
Journal Article
Open access
PDF file
ABAndreia Bilé-Silva
Andreia Bilé-Silva
MÖMEHMET ÖZALEVLİ
MEHMET ÖZALEVLİ
GCGabriel Chan
Gabriel Chan
SASyed Ahmed
Syed Ahmed
ZTZafer Tandogdu
Zafer Tandogdu
Background/Objectives: Prostate cancer (PCa) incidence is rising, with radical prostatectomy (RP) as the main curative surgery for localised cases, which includes removing seminal vesicles (SV). SV invasion (SVI) predicts poor oncological outcomes, making accurate preoperative staging to identify SVI crucial for surgical planning. This ensures oncological safety by enabling wide excision when needed, while preserving tissue to maintain function. This review synthesises current evidence on pre-biopsy MRI findings and/or clinicopathological parameters to diagnose SVI in PCa. Methods: A literature search (2005–2025) using OVID for studies assessing pre-biopsy MRI findings, with a priori eligibility for clinicopathological or combined MRI–clinicopathological models (index tests), for detecting SVI (outcome) compared to RP histopathology (standard reference) in patients with primary localised PCa (patients). This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Risk of bias was evaluated with QUADAS-2, and pooled diagnostic accuracy metrics and study heterogeneity were analysed. Results: Five studies qualified, while three used binary mpMRI classification and were quantitatively analysed. No eligible studies assessed clinicopathological predictors or combined MRI–clinicopathological models; all included studies evaluated pre-biopsy MRI findings only, and none included high-dimensional radiomics. The pooled sensitivity was 0.66 (95% CI: 0.52–0.78), specificity 0.94 (0.89–0.97), positive predictive value (PPV) 0.76 (0.60–0.87), negative predictive value (NPV) 0.92 (0.85–0.94), and diagnostic odds ratio 30.13 (12.36–73.47), with moderate heterogeneity. All included studies were retrospective cohorts with considerable risk of bias. Conclusions: In the small number of heterogeneous, single-centre retrospective studies available, pre-biopsy MRI findings show high specificity and NPV for preoperative detection of SVI but only moderate sensitivity, which limits its reliability as a standalone tool. The pooled diagnostic accuracy estimates should be interpreted as exploratory. These findings should therefore be interpreted cautiously. Future studies must integrate MRI with clinicopathological data, addressing this key evidence gap before firm conclusions can be drawn or clinical practice changed.